Triple Combination of Pevonedistat and Venetoclax Plus Azacitidine in Adults With Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy

Condition:   Acute Myeloid Leukemia Interventions:   Drug: Pevonedistat;   Drug: Venetoclax;   Drug: Azacitidine Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials